Has Robert Harnick received payments from drug or device companies?

Yes. Drug and device makers reported $2,753 in general payments to Robert Harnick across 175 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Harnick did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Harnick come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Harnick

Child & Adolescent Psychiatry · Saratoga Springs, NYNPI 1932264769

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 28.2% of the total.

$2,753in general payments, 2019–2025

Across 175 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$775
Teva Pharmaceuticals USA, Inc.$571
Neurocrine Biosciences, Inc.$364
Johnson & Johnson$316
Vanda Pharmaceuticals Inc.$140
Alkermes, Inc.$127
plus $459 from 10 others

What the payments were for

Food & beverage$2,753100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	53	$775
Teva Pharmaceuticals USA, Inc.	35	$571
Neurocrine Biosciences, Inc.	22	$364
Johnson & Johnson	20	$316
Vanda Pharmaceuticals Inc.	6	$140
Alkermes, Inc.	6	$127
Lundbeck LLC	5	$114
Sunovion Pharmaceuticals Inc.	13	$95
AbbVie	4	$80
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$46
Supernus Pharmaceuticals, Inc.	2	$30
Ironshore Pharmaceuticals Inc.	2	$26
Axsome Therapeutics, Inc.	1	$20
Idorsia Pharmaceuticals US Inc	1	$19
Jazz Pharmaceuticals Inc.	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$11

How this compares

$2,753 in reported general payments places this provider in the 85th percentile of 317 child & adolescent psychiatry providers in New York.

See all child & adolescent psychiatry providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	25	$8,299
Divalproex Sodium ErDivalproex Sodium	13	$2,350
Clonazepam	27	$665
Fluoxetine Hcl	18	$410
Risperidone	13	$317
Benztropine Mesylate	13	$279

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Saratoga Springs

Matthew LorberNew York$398K
Mitchell CabisudoNew Windsor$346K
Parinda ParikhWhite Plains$185K
Jeffrey NewcornNew York$165K
John MarinoCanandaigua$70K
Iliyan IvanovNew York$38K
Melvin OatisNew York$35K
Vijay PampanaMiddletown$19K
Marc ReitmanHuntington$13K
Marie CharlesBrooklyn$11K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →